<br /> <b>Warning</b>: Undefined array key "mm" in <b>/www/wwwroot/www.ai-bt.com/si.php</b> on line <b>10</b><br /> <br /> <b>Deprecated</b>: trim(): Passing null to parameter #1 ($string) of type string is deprecated in <b>/www/wwwroot/www.ai-bt.com/si.php</b> on line <b>10</b><br /> Extrapolation of trial results suggests that aspirin is useful in intermittent claudication.

Literature DB >> 9836671

Extrapolation of trial results suggests that aspirin is useful in intermittent claudication.

P Gresele, R Migliacci.

Abstract

Entities: Chemical Disease

Year: 1998 PMID： 9836671 PMCID： PMC1114396 DOI： 10.1136/bmj.317.7172.1587a

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

Keyword Cloud
References

× No keyword cloud information.

5 in total

1. Targeting subclinical atherosclerosis. Has the potential to reduce coronary events dramatically.

Authors: F G Fowkes; J F Price; G C Leng
Journal: BMJ Date: 1998-06-13

Review 2. North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

Authors: M Eccles; N Freemantle; J Mason
Journal: BMJ Date: 1998-04-25

3. Aspirin after myocardial infarction.

Authors:
Journal: Lancet Date: 1980-05-31 Impact factor: 79.321

4. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

Authors:
Journal: Lancet Date: 1998-01-24 Impact factor: 79.321

5. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors:
Journal: BMJ Date: 1994-01-08

5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.